- Medical Malpractice
- Product
- Unsafe Drugs
- Bisphosphonate Litigation
- Bextra Litigation
- Silicone Gel Breast Implant Litigation
- Fen-Phen Diet Drugs
- Guidant Defibrillators
- Hormone Replacement Drugs
- Kugel Hernia Mesh Patches
- Medtronic Sprint Fidelis Lead
- Mentor ObTape Trans-Obturator Tape Litigation
- Ortho Evra Birth Control Patch
- Bausch & Lomb's ReNu with MoistureLoc Contact Lens Solution
- Vioxx Litigation
- Shoulder Pain Pumps
- Medtronic Defibrillator Litigation
- Other/Archive Drug Products
- Personal Injuries
- Auto Accidents
- Nursing Home Abuse
Unsafe Drugs and Medical Products
Our partners have more than 100 combined years of experience in litigating complex personal injury, products liability, and medical malpractice claims. We have also successfully represented over 10,000 plaintiffs in pharmaceutical and medical device claims involving Vioxx, Bextra, hormone replacement therapy drugs, Guidant and Medtronic heart devices, breast implants, diet drugs, Baycol, Sulzer hip and knee implants, PPA, ProteGen bladder slings, ReNu contact lens solution, and a number of other drug and medical device claims.
Please visit our Verdicts & Settlements Section for information about some of our previous cases. If you or someone you love has been harmed by an unsafe drug or medical product, contact Alley, Clark, Greiwe & Fulmer for a free consultation regarding your claim.
Unsafe Drugs:
- Bisphosphonate Litigation
- Bextra Litigation
- Silicone Gel Breast Implant Litigation
- Fen-Phen Diet Drugs
- Hormone Replacement Drugs
- Kugel Hernia Mesh Patches
- Medtronic Sprint Fidelis Lead
- Mentor ObTape Trans-Obturator Tape Litigation
- Ortho Evra Birth Control Patch
- Bausch & Lomb’s ReNu with MoistureLoc Contact Lens Solution
- Vioxx Litigation
- Shoulder Pain Pumps
- Other/Archive Drug Products
Related archive articles:
- Off–label use of drugs
- Clinical Trial Participants Get Little FDA Protection
- FDA Plans to Accelerate Generic Drug Review
- Merck Sued by State of New York Over Vioxx
- State Suing Drug Companies for Fraud
- FDA Appoints Members of Risk Communication Panel
- Advisory Panel Says FDA Needs Recall Power
- GE Facing Litigation Over MRI Drug Omniscan